Madrigal Pharmaceuticals, Inc. MDGL Total costs & expenses
Total costs & expenses at other companies
Other financials
Where this comes from
Reported directly by Madrigal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingCostsAndExpenses.
The official record: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Madrigal Pharmaceuticals, Inc.'s total costs & expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Madrigal Pharmaceuticals, Inc.'s total costs & expenses?
- Madrigal Pharmaceuticals, Inc. (MDGL) reported total costs & expenses of $26.85M in Q1 2026.
- How has Madrigal Pharmaceuticals, Inc.'s total costs & expenses changed year-over-year?
- Madrigal Pharmaceuticals, Inc.'s total costs & expenses increased by 494.9% year-over-year, from $4.51M to $26.85M.
- What is the long-term trend for Madrigal Pharmaceuticals, Inc.'s total costs & expenses?
- Over 3 years (2022 to 2025), Madrigal Pharmaceuticals, Inc.'s total costs & expenses has grown at a -42.4% compound annual growth rate (CAGR), from $293.57M to $56.15M.
- What does total costs & expenses mean?
- The sum of all expenditures required to run the business during a specific period.
- How do you interpret total costs & expenses?
- An increase may signal scaling operations or rising costs, while a decrease suggests cost-cutting measures or improved operational efficiency.
- How does total costs & expenses compare across companies?
- Biotech companies often have high total expenses relative to revenue due to heavy investment in clinical trials and commercial infrastructure.